血浆FGF21水平与肌肉质量及肌肉力量的关联:韩国衰弱与老龄化队列研究
该研究基于韩国衰弱与老龄化队列中386名70-84岁社区居住老年人,分析血浆成纤维细胞生长因子21(FGF21)与四肢骨骼肌质量及握力的关联。结果显示FGF21与肌肉力量呈负相关,但与肌肉质量无独立相关;最高FGF21四分位组较低四分位组低肌肉力量风险比为2.32(95%CI 1.20-4.46)。
要点
- 低肌肉质量组血浆FGF21显著低于正常肌肉质量组(P=0.008)。
- 低肌肉力量组血浆FGF21显著高于正常肌肉力量组(P=0.006)。
- 多因素校正后,最高FGF21四分位组低肌肉力量风险为最低组的2.32倍(95%CI 1.20-4.46)。
核心结论
- 循环FGF21水平与肌肉力量呈负相关,但与肌肉质量无独立相关性。
研究设计与样本
- 基于韩国衰弱与老龄化队列研究的横断面分析,纳入386名70-84岁社区居住老年人。
主要发现
- 低肌肉质量组血浆FGF21为289.7(192.4-448.3)pg/ml,显著低于正常肌肉质量组的345.6(238.6-503.2)pg/ml(P=0.008)。
- 低肌肉力量组血浆FGF21为369.7(244.4-591.1)pg/ml,显著高于正常肌肉力量组的309.7(205.3-444.8)pg/ml(P=0.006)。
- 校正年龄、性别和体重指数后,FGF21与ASM/ht2无显著关联,但与握力呈负相关(r=-0.112,P=0.029)。
- 多因素校正后,最高与最低FGF21四分位组相比,低肌肉力量风险比为2.32(95%CI 1.20-4.46)。
关键数值与推荐
- 低肌肉质量和低肌肉力量的判定依据亚洲肌少症工作组(AWGS)标准。
临床怎么用
- 在老年肌少症评估中,血浆FGF21可能作为反映肌肉力量下降的候选生物标志物,但尚不能替代肌肉质量评估。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: despite of the beneficial effects of fibroblast growth factor (FGF) 21 in several metabolic diseases, the association of plasma FGF21 with muscle mass and muscle strength is still unclear. METHODS: a total of 386 community-dwelling older adults aged 70-84 years were analysed. Appendicular skeletal muscle mass was measured using dual-energy X-ray absorptiometry and normalised to the square of height (ASM/ht2). Muscle strength was assessed using the hand grip strength (HGS) test. The definitions of low muscle mass (LMM) and low muscle strength (LMS) were based on the Asian Working Group for Sarcopenia. RESULTS: plasma FGF21 was significantly lower in participants with LMM than in those with normal muscle mass (289.7 [192.4-448.3] vs. 345.6 [238.6-503.2] pg/ml, P = 0.008). In contrast, the LMS group had a significantly higher plasma FGF21 level than the normal muscle strength group (369.7 [244.4-591.1] vs. 309.7 [205.3-444.8] pg/ml, P = 0.006). In the partial correlation analysis, following adjustment for age, sex and body mass index, FGF21 levels had no significant association with ASM/ht2, but were negatively associated with HGS (r = -0.112, P = 0.029). Furthermore, after multivariate adjustment for confounding variables, the odds ratio for the risk of LMS was 2.32 (95% confidence interval 1.20-4.46) when comparing the highest with the lowest FGF21 quartile. CONCLUSIONS: circulating FGF21 levels are negatively associated with muscle strength but are not independently correlated with muscle mass.
引用
- Roh E, Hwang SY, Yoo HJ, et al. Association of plasma FGF21 levels with muscle mass and muscle strength in a national multicentre cohort study: Korean Frailty and Aging Cohort Study. Age Ageing. 2021. PMID: 34591968. doi:10.1093/ageing/afab178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。